QQQ   427.15 (+0.31%)
AAPL   167.81 (-0.11%)
MSFT   411.62 (-0.05%)
META   508.67 (+2.93%)
GOOGL   155.94 (+0.30%)
AMZN   182.22 (+0.52%)
TSLA   150.11 (-3.44%)
NVDA   859.37 (+2.26%)
AMD   156.53 (+1.63%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.11 (+0.58%)
MU   113.99 (-2.01%)
GE   156.51 (+0.54%)
CGC   7.66 (+18.03%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.32 (-0.39%)
PYPL   62.68 (-0.92%)
XOM   118.77 (+0.12%)
QQQ   427.15 (+0.31%)
AAPL   167.81 (-0.11%)
MSFT   411.62 (-0.05%)
META   508.67 (+2.93%)
GOOGL   155.94 (+0.30%)
AMZN   182.22 (+0.52%)
TSLA   150.11 (-3.44%)
NVDA   859.37 (+2.26%)
AMD   156.53 (+1.63%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.11 (+0.58%)
MU   113.99 (-2.01%)
GE   156.51 (+0.54%)
CGC   7.66 (+18.03%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.32 (-0.39%)
PYPL   62.68 (-0.92%)
XOM   118.77 (+0.12%)
QQQ   427.15 (+0.31%)
AAPL   167.81 (-0.11%)
MSFT   411.62 (-0.05%)
META   508.67 (+2.93%)
GOOGL   155.94 (+0.30%)
AMZN   182.22 (+0.52%)
TSLA   150.11 (-3.44%)
NVDA   859.37 (+2.26%)
AMD   156.53 (+1.63%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.11 (+0.58%)
MU   113.99 (-2.01%)
GE   156.51 (+0.54%)
CGC   7.66 (+18.03%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.32 (-0.39%)
PYPL   62.68 (-0.92%)
XOM   118.77 (+0.12%)
QQQ   427.15 (+0.31%)
AAPL   167.81 (-0.11%)
MSFT   411.62 (-0.05%)
META   508.67 (+2.93%)
GOOGL   155.94 (+0.30%)
AMZN   182.22 (+0.52%)
TSLA   150.11 (-3.44%)
NVDA   859.37 (+2.26%)
AMD   156.53 (+1.63%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.11 (+0.58%)
MU   113.99 (-2.01%)
GE   156.51 (+0.54%)
CGC   7.66 (+18.03%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.32 (-0.39%)
PYPL   62.68 (-0.92%)
XOM   118.77 (+0.12%)

Synthorx (THOR) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
seekingalpha.com logoDesign Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 21 at 4:55 PM
insidermonkey.com logoDesign Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
insidermonkey.com - March 20 at 3:52 PM
finance.yahoo.com logoEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer
finance.yahoo.com - March 14 at 10:35 AM
finance.yahoo.com logoEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors
finance.yahoo.com - December 19 at 10:44 AM
uk.finance.yahoo.com logoBiosimilar Interleukins Global Market Report 2023
uk.finance.yahoo.com - February 16 at 10:03 AM
uk.finance.yahoo.com logoImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors - Yahoo Finance UK
uk.finance.yahoo.com - October 4 at 2:57 PM
businesswire.com logoCapstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering - Business Wire
businesswire.com - September 14 at 8:34 AM
businesswire.com logoMedikine Initiates First Clinical Trial of its Lead Program, an Interleukin-7 Mimetic, Under Management Team with Expertise in Next-Generation Cytokine Drug Discovery and Development - Business Wire
businesswire.com - July 19 at 5:48 PM
streetinsider.com logoForm SC 14D9 Turning Point Therapeuti Filed by: Turning Point Therapeutics, Inc. - StreetInsider.com
streetinsider.com - June 17 at 11:06 PM
seekingalpha.com logoVBK: Why Growth Investors Should Avoid The Small-Caps (NYSEARCA:VBK) - Seeking Alpha
seekingalpha.com - June 9 at 5:02 PM
finance.yahoo.com logoElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development - Yahoo Finance
finance.yahoo.com - June 2 at 8:25 AM
streetinsider.com logoForm DEF 14A Janux Therapeutics, Inc. For: Jun 14 - StreetInsider.com
streetinsider.com - April 30 at 2:26 AM
nasdaq.com logoU.S. Stocks Pull Back Sharply, Contributing To Nasdaq's Worst Month Since 2008 - Nasdaq
nasdaq.com - April 29 at 9:25 PM
fool.com logoSanofi (SNY) Q1 2022 Earnings Call Transcript - The Motley Fool
fool.com - April 29 at 9:25 PM
finance.yahoo.com logoGlobal Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application, By Type, By Regional Outlook and Forecast, 2021 - 2027 - Yahoo Finance
finance.yahoo.com - April 4 at 8:40 AM
streetinsider.com logoGennao Bio Strengthens Board of Directors with Appointments of Peter Thompson, MD, and Bradley Campbell - StreetInsider.com
streetinsider.com - March 17 at 6:46 PM
nz.finance.yahoo.com logoImmuno-Oncology Drugs Global Market Report 2022
nz.finance.yahoo.com - March 8 at 10:07 AM
benzinga.com logoImmuno-Oncology Drugs Global Market Report 2022 - Benzinga - Benzinga
benzinga.com - March 5 at 12:01 AM
benzinga.com logoA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - Benzinga - Benzinga
benzinga.com - March 3 at 5:27 PM
finance.yahoo.com logoProtein Inhibitors Global Market Report 2022 - Yahoo Finance
finance.yahoo.com - March 3 at 7:47 AM
prnewswire.com logoA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - PR Newswire
prnewswire.com - March 3 at 7:47 AM
finance.yahoo.com logoImmuno-Oncology Drugs Global Market Report 2022 - Yahoo Finance
finance.yahoo.com - March 3 at 7:47 AM
businesswire.com logoOrbiMed Names Two New General Partners - Business Wire
businesswire.com - December 7 at 2:59 PM
streetinsider.com logoOrbiMed Names Two New General Partners - StreetInsider.com
streetinsider.com - December 7 at 9:56 AM
seekingalpha.com logoMedicenna Therapeutics: Treating Cancer With Immunomodulators - Seeking Alpha
seekingalpha.com - November 13 at 10:08 AM
seekingalpha.com logoNektar: The Anatomy Of A Shakedown - Seeking Alpha
seekingalpha.com - November 10 at 1:57 PM
finance.yahoo.com logoOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
finance.yahoo.com - October 28 at 9:53 AM
streetinsider.com logoOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer - StreetInsider.com
streetinsider.com - October 26 at 12:06 PM
globenewswire.com logoJoint Pain Injections Market Surpass - US$ 10.3 Bn by 2028 - GlobeNewswire
globenewswire.com - September 30 at 11:41 AM
businesswire.com logoImmuno-Oncology Drugs Global Market Report 2021 - ResearchAndMarkets.com - Business Wire
businesswire.com - September 29 at 3:38 PM
finance.yahoo.com logoBiosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030 - Yahoo Finance
finance.yahoo.com - September 27 at 8:24 AM
uk.finance.yahoo.com logoImmuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
uk.finance.yahoo.com - September 24 at 10:07 AM
seekingalpha.com logoNektar And Bristol Myers Squibb Expecting Bempeg Approval - Seeking Alpha
seekingalpha.com - September 18 at 10:29 AM
nasdaq.com logoSanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock - Nasdaq
nasdaq.com - September 8 at 4:27 PM
businessinsider.com logoMeet the top young leaders transforming the biotech industry
businessinsider.com - September 8 at 8:57 AM
fortune.com logoWill only a handful of companies solve the childcare crisis? - Fortune
fortune.com - August 24 at 7:56 AM
yahoo.com logoAristea Appoints Justin Thacker as Chief Financial Officer - Yahoo Finance
yahoo.com - August 23 at 4:55 PM
markets.businessinsider.com logoAristea Appoints Justin Thacker as Chief Financial Officer - Markets Insider
markets.businessinsider.com - August 23 at 8:29 AM
seekingalpha.com logoSanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 29 at 7:35 PM
Get Synthorx News Delivered to You Automatically

Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter.

A.I. Pioneer Issues Urgent Warning to Americans (Ad)

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

THOR Media Mentions By Week

THOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

THOR
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

THOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

THOR Articles
This Week

0

0

THOR Articles
Average Week

Get Synthorx News Delivered to You Automatically

Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:THOR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners